Antineoplastic Drug NewsLatest News On Antineoplastic Drug Cabozantinib Improves PFS in Advanced Neuroendocrine Tumors After Prior Treatment2/13/2025 8:10 AM Last Month in Oncology: FDA Cancer News Roundup2/4/2025 10:02 AM Baricitinib Shows Promise in Polymyalgia Rheumatica1/22/2025 3:48 AM Trastuzumab Emtansine Ups Long-Term Survival in HER2-Positive Breast Cancer1/16/2025 9:15 AM Can Some Patients Safely Skip Postmastectomy Radiation?1/9/2025 10:56 AM Rituximab and Abatacept May Contribute to Cancer Risk in Patients With Rheumatoid Arthritis12/13/2024 6:15 AM Eye Toxicities Are a Growing Concern With Certain ADCs12/11/2024 8:04 AM Acalabrutinib Combo Promising as Frontline Treatment for CLL12/11/2024 5:10 AM Real-World Data Question Low-Dose Steroid Use in Vasculitis12/8/2024 11:32 PM Intratumoral Dendritic Cell Therapy Shows Promise in Early-Stage ERBB2–Positive Breast Cancer12/6/2024 6:15 AM Low-Dose Steroids Prevent GPA Relapse, With Caveats11/17/2024 4:37 PM From Mexico City to the Heights of Leukemia Medicine11/15/2024 7:11 AM Rituximab Not Inferior to Cyclophosphamide in Pediatric Vasculitis11/11/2024 5:26 AM Why a Failed Confirmatory Trial May Not Mean a Failed Drug11/8/2024 5:40 AM Myasthenia Gravis: Where Does Traditional Therapy Fit in?11/4/2024 3:52 AM Michigan Oncologist Charged in Scheme to Illegally Sell Cancer Drugs10/31/2024 7:45 AM Trastuzumab Duocarmazine Ups PFS, Ocular Toxicity in Advanced HER2+ Breast Cancer10/31/2024 6:38 AM Expert Updates Therapy for Waldenström Macroglobulinemia10/24/2024 9:09 AM Pediatric Myasthenia Gravis: Don’t Treat Kids Like Adults10/22/2024 4:08 AM First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis10/17/2024 5:12 AM
